Hepatocyte growth factor activator inhibitor-2 (HAI-2) is a favorable prognosis marker and inhibits cell growth through the apoptotic pathway in cervical cancer

K. Nakamura1* F. Abarzua2 A. Hongo1 J. Kodama1 Y. Nasu2 H. Kumon2 and Y. Hiramatsu1

首页> 外文期刊>Annals of Oncology >Hepatocyte growth factor activator inhibitor-2 (HAI-2) is a favorable prognosis marker and inhibits cell growth through the apoptotic pathway in cervical cancer

【24h】

Hepatocyte growth factor activator inhibitor-2 (HAI-2) is a favorable prognosis marker and inhibits cell growth through the apoptotic pathway in cervical cancer

机译：肝细胞生长因子激活物抑制剂2（HAI-2）是一种良好的预后标志物，可通过凋亡途径抑制宫颈癌中的细胞生长

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: In light of the poor prognosis for cervical cancer, research continues into the development of innovative and efficacious treatment modalities for this disease. We investigated the role of hepatocyte growth factor activator inhibitor-2 (HAI-2) and evaluated its clinical importance in cervical cancer.

机译：背景：鉴于宫颈癌的预后不良，因此继续研究开发针对该疾病的创新且有效的治疗方式。我们调查了肝细胞生长因子激活物抑制剂2（HAI-2）的作用，并评估了其在宫颈癌中的临床重要性。

著录项

来源
《Annals of Oncology》 |2009年第1期|p.63-70|共8页
作者
K. Nakamura1* F. Abarzua2 A. Hongo1 J. Kodama1 Y. Nasu2 H. Kumon2 and Y. Hiramatsu1;
展开▼
作者单位

1Department of Obstetrics and Gynecology 2Department of Urology, Okayama University Graduate School of Medical, Dentistry and Pharmaceutical Sciences, Okayama, Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Hepatocyte growth factor activator inhibitor-2 (HAI-2) is a favorable prognosis marker and inhibits cell growth through the apoptotic pathway in cervical cancer. [J] . Nakamura K, Abarzua F, Hongo A, Annals of oncology: official journal of the European Society for Medical Oncology . 2009,第1期

机译：肝细胞生长因子激活物抑制剂2（HAI-2）是一种良好的预后标志物，可通过凋亡途径抑制宫颈癌中的细胞生长。
2. Author Correction: The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells [J] . Shang-Ru Wu, Chen-Hsin Teng, Ya-Ting Tu, Scientific reports. . 2020,第1期

机译：作者校正：肝细胞生长因子活化剂抑制剂-2的Kunitz结构域I抑制人前列腺癌细胞的矩阵活性和侵入能力
3. The Kunitz domain I of hepatocyte growth factor activator inhibitor-2 is important for suppressing matriptase activity and human prostate cancer cell invasion [J] . Wu Shang-Ru, Huang Hsiang-Po, Teng Chen-Hsin, Clinical and experimental metastasis . 2017,第8期

机译：肝细胞生长因子活化剂抑制剂-2的Kunitz结构域I对于抑制矩阵活性和人前列腺癌细胞侵袭是重要的
4. Treating mesenchymal stem cells with hepatocyte growth factor enhances cardiac markers [C] . Guyette J.P., Gaudette G.R. IEEE Annual Northeast Bioengineering Conference . 2009

机译：用肝细胞生长因子治疗间充质干细胞可增强心脏标志物
5. SIX1 maintains tumor basal cells via transforming growth factor-β pathway and associates with poor prognosis in esophageal cancer [D] . Nishimura, Takao 2019

机译：SIX1通过转化生长因子-β途径维持肿瘤基底细胞并与食管癌预后不良相关
6. Hepatocyte growth factor activator inhibitor type-2 (HAI-2)/SPINT2 contributes to invasive growth of oral squamous cell carcinoma cells [O] . Koji Yamamoto, Makiko Kawaguchi, Takeshi Shimomura, 2018

机译：2型肝细胞生长因子激活因子抑制剂（HAI-2）/ SPINT2促进口腔鳞状细胞癌细胞的侵袭性生长
7. Hepatocyte growth factor activator inhibitor-2 (HAI-2) is a favorable prognosis marker and inhibits cell growth through the apoptotic pathway in cervical cancer [O] . K. Nakamura, F. Abarzua, A. Hongo, 2009

机译：肝细胞生长因子活化剂抑制剂-2（HAI-2）是一种良好的预后标志物，并通过宫颈癌中的凋亡途径抑制细胞生长

Hepatocyte growth factor activator inhibitor-2 (HAI-2) is a favorable prognosis marker and inhibits cell growth through the apoptotic pathway in cervical cancer

摘要

著录项

相似文献

相关主题

期刊订阅